Literature DB >> 28813226

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Orrin Devinsky1, J Helen Cross2, Stephen Wright3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28813226     DOI： 10.1056/NEJMc1708349

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  42 in total

Review 1.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

2.  Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.

Authors:  Charles M Skinner; Intawat Nookaew; Laura E Ewing; Thidathip Wongsurawat; Piroon Jenjaroenpun; Charles M Quick; Eric U Yee; Brian D Piccolo; Mahmoud ElSohly; Larry A Walker; Bill Gurley; Igor Koturbash
Journal:  J Diet Suppl       Date:  2020-05-13

Review 3.  Changing landscape of cannabis: novel products, formulations, and methods of administration.

Authors:  Tory R Spindle; Marcel O Bonn-Miller; Ryan Vandrey
Journal:  Curr Opin Psychol       Date:  2019-04-09

4.  Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.

Authors:  Marta Vázquez; Carlos García-Carnelli; Cecilia Maldonado; Pietro Fagiolino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol.

Authors:  Yukako Nakano; Masataka Tajima; Erika Sugiyama; Vilasinee Hirunpanich Sato; Hitoshi Sato
Journal:  Med Cannabis Cannabinoids       Date:  2019-04-04

6.  Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue.

Authors:  Robert B Child; Mark J Tallon
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

7.  The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders.

Authors:  Qing Xin; Fei Xu; Devin H Taylor; Jing-Fu Zhao; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2020-10-06       Impact factor: 6.150

8.  dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.

Authors:  Gaia Colasante; Gabriele Lignani; Simone Brusco; Claudia Di Berardino; Jenna Carpenter; Serena Giannelli; Nicholas Valassina; Simone Bido; Raffaele Ricci; Valerio Castoldi; Silvia Marenna; Timothy Church; Luca Massimino; Giuseppe Morabito; Fabio Benfenati; Stephanie Schorge; Letizia Leocani; Dimitri M Kullmann; Vania Broccoli
Journal:  Mol Ther       Date:  2019-09-03       Impact factor: 11.454

9.  Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.

Authors:  Tory R Spindle; Edward J Cone; David Kuntz; John M Mitchell; George E Bigelow; Ronald Flegel; Ryan Vandrey
Journal:  J Anal Toxicol       Date:  2020-03-07       Impact factor: 3.220

10.  Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.

Authors:  Tory R Spindle; Edward J Cone; Elia Goffi; Elise M Weerts; John M Mitchell; Ruth E Winecker; George E Bigelow; Ronald R Flegel; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2020-04-01       Impact factor: 4.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.